We are live on
!
Find out more
BDS
Banco de Sabadell Portfolio holdings
AUM
$170M
1-Year Est. Return
26.61%
This Fund
S&P 500
This Quarter
Est. Return
+5.55%
1 Year Est. Return
+26.61%
3 Year Est. Return
+75.08%
5 Year Est. Return
+103.03%
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$838K
(+0.7%)
Cap. Flow
-$3.8M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
33.98%
Holding
81
New
1
Increased
30
Reduced
42
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Europe Financials ETF
EUFN
|
+$887K |
| 2 |
Medtronic
MDT
|
+$360K |
| 3 |
Truist Financial
TFC
|
+$250K |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$166K |
| 5 |
Equinor
EQNR
|
+$165K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$555K |
| 2 |
Valero Energy
VLO
|
+$527K |
| 3 |
Mastercard
MA
|
+$502K |
| 4 |
McDonald's
MCD
|
+$453K |
| 5 |
Microsoft
MSFT
|
+$358K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25% |
| 2 | Healthcare | 15.74% |
| 3 | Financials | 12.77% |
| 4 | Consumer Staples | 11.66% |
| 5 | Consumer Discretionary | 11.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABB
51
DELISTED
ABB Ltd
ABB
| $792K | 0.66% |
23,038
-957
| -4% | -$32.1K |
|
52
Novartis
NVS
$291B
| $787K | 0.66% |
8,517
+828
| +11% | +$72.3K |
|
53
Baxter International
BAX
$14.7B
| $739K | 0.62% |
18,180
-1,134
| -6% | -$48.1K |
|
54
British American Tobacco
BTI
$128B
| $625K | 0.52% |
17,805
-779
| -4% | -$29.4K |
|
|
55
Alphabet (Google) Class C
GOOG
$4.59T
| $493K | 0.41% |
4,818
+1,722
| +56% | +$166K |
|
56
nVent Electric
NVT
$26.3B
| $473K | 0.39% |
10,997
-463
| -4% | -$19.5K |
|
57
Berkshire Hathaway Class B
BRK.B
$1.12T
| $408K | 0.34% |
1,331
+422
| +46% | +$130K |
|
58
Autoliv
ALV
$9.12B
| $393K | 0.33% |
4,222
-165
| -4% | -$14.6K |
|
59
AstraZeneca
AZN
$241B
| $381K | 0.32% |
2,723
-114
| -4% | -$15.3K |
|
60
Salesforce
CRM
$156B
| $281K | 0.23% |
1,420
+520
| +58% | +$87.8K |
|
61
NVIDIA
NVDA
$5.13T
| $229K | 0.19% |
8,350
+2,650
| +46% | +$57.4K |
|
62
Vertex Pharmaceuticals
VRTX
$121B
| $182K | 0.15% |
579
| – | – |
|
63
Alibaba
BABA
$309B
| $172K | 0.14% |
1,689
+604
| +56% | +$60.5K |
|
64
Thermo Fisher Scientific
TMO
$209B
| $164K | 0.14% |
291
+96
| +49% | +$54.1K |
|
65
ExxonMobil
XOM
$638B
| $157K | 0.13% |
1,440
+718
| +99% | +$79.4K |
|
66
Boeing
BA
$187B
| $144K | 0.12% |
686
+217
| +46% | +$45.1K |
|
67
AbbVie
ABBV
$431B
| $133K | 0.11% |
838
+359
| +75% | +$54.9K |
|
68
Tesla
TSLA
$1.29T
| $129K | 0.11% |
648
+340
| +110% | +$59.3K |
|
69
iShares US Medical Devices ETF
IHI
$3.36B
| $117K | 0.1% |
2,192
| – | – |
|
70
Citigroup
C
$230B
| $101K | 0.08% |
2,179
+940
| +76% | +$46.1K |
|
71
Visa
V
$690B
| $92K | 0.08% |
413
+54
| +15% | +$12K |
|
72
Lockheed Martin
LMT
$136B
| $88K | 0.07% |
185
+106
| +134% | +$49.7K |
|
73
Estee Lauder
EL
$31.5B
| $76K | 0.06% |
310
+35
| +13% | +$8.89K |
|
74
SLB Ltd
SLB
$75.4B
| $73K | 0.06% |
1,490
+517
| +53% | +$27.5K |
|
75
Wells Fargo
WFC
$267B
| $72K | 0.06% |
1,921
+1,362
| +244% | +$59.4K |
|
Similar funds
AWA
AGC
DWM
RFO
BM
BFG
SFP
CAS
Banco de Sabadell's Q1 2023 Portfolio in Review
As of Q1 2023, Banco de Sabadell held 81 positions worth $120M, up 0.7% from $119M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Banco de Sabadell withdrew a net $3.8M in Q1 2023, closing 2 positions and reducing 42 holdings. Its most notable exit was GSK, an estimated $260K position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Banco de Sabadell opened a new position in iShares MSCI Europe Financials ETF worth $860K.
- Banco de Sabadell's largest Q1 2023 buy was iShares MSCI Europe Financials ETF: 46,194 shares worth $860K.
- Banco de Sabadell added most to Medtronic in Q1 2023, an estimated $360K increase.
- Banco de Sabadell's biggest Q1 2023 reduction was Stryker, cutting an estimated $555K.
- Banco de Sabadell fully exited GSK in Q1 2023, selling an estimated $260K.
- Banco de Sabadell's ten largest holdings make up 34% of its $120M portfolio in Q1 2023.
- Banco de Sabadell opened 1 new position and closed 2 in Q1 2023.
- Banco de Sabadell's portfolio value rose 0.7% quarter-over-quarter to $120M.
Based on Banco de Sabadell's 13F filing for Q1 2023, filed 12 May 2023.